Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
A Phase III Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy SRT versus Surgically Targeted Radiation Therapy STaRT with Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors.
A Phase 2 Study of Dabrafenib NSC 763760 with Trametinib NSC 763093 after Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma HGG
Study Type: Treatment
Phase: II
NCTID: NCT03919071
Principal Investigator:
Keith August
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
Study Type: Treatment
Phase: II
NCTID: NCT04696029
Principal Investigator:
Kevin Ginn
Feasibility Study of Resection and GammaTile Followed by Concomitant External Beam Radiation Therapy EBRT and Temozolomide TMZ and Adjuvant TMZ in Newly Diagnosed Glioblastoma GBM.
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT05342883
Principal Investigator:
Tolga Tuncer
A Phase 1/2 Trial of Selinexor KPT-330 and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma DIPG and High-Grade Glioma HGG
Study Type: Treatment
Phase: I/II
NCTID: NCT05099003
Principal Investigator:
Keith August
Phase III Trial Of Post-Surgical Single Fraction Stereotactic Radiosurgery SRS Compared With Fractionated SSs FSRS For Resected Metastatic Brain Disease
A Randomized Phase II Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination with Atezolizumab Compared to Atezolizumab Alone in Subjects with Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where cisplatin-Based Treatment is Not an Option
A Safety Run-In And Phase II Study Evaluating The Efficacy, Safety, And Impact On The Tumor Microenvironment Of The Combination Of Tocilizumab, Atezolizumab, And Fractionated Stereotactic Radiotherapy In Recurrent Glioblastoma
Study Type: Treatment
Phase: II
NCTID: NCT04729959
Principal Investigator:
Tolga Tuncer
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Study Type: Treatment
Phase: II
NCTID: NCT02724579
Principal Investigator:
Keith August